NDC11 59917010201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59917-0102-01 | 59917-0102 |
| 59917-0102-1 | 59917-0102 |
| 59917-102-01 | 59917-102 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Adare Pharmaceuticals Inc | 22edb0e6-4e45-4e91-aead-3581cca293a0 | 2023-12-20 | Warnings, Adverse reactions | 59917-102-01 59917-102 59917010201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.